News
Community Safety Department Director To Resign Amid Tension With Cambridge Police Department
News
From Lab to Startup: Harvard’s Office of Technology Development Paves the Way for Research Commercialization
News
People’s Forum on Graduation Readiness Held After Vote to Eliminate MCAS
News
FAS Closes Barker Center Cafe, Citing Financial Strain
News
8 Takeaways From Harvard’s Task Force Reports
With an immune system designed to destroy invading organisms, patients receiving organ transplants often run the risk of becoming their own worst enemies.
But by transferring some of the donor’s bone marrow along with the organs, two Medical School researchers have found a way to fool immune cells into accepting foreign tissue as well. Four of the five study’s subjects received successful transplants.
Researchers believe the new procedure, which begins with a partial destruction of the patient’s bone marrow using a drug, may decrease organ rejection. The bone marrow gives rise to immune cells that help the body identify invaders. If the foreign marrow produces foreign cells, the study’s authors hypothesized that the body will recognize the transplant as one of its own.
But the researchers, David H. Sachs and A. Benedict Cosimi, are looking beyond mere human transplants. They’ve already filed a patent for transplants from animals to humans.
For recent research, faculty profiles, and a look at the issues facing Harvard scientists, check out The Crimson's science page.
Want to keep up with breaking news? Subscribe to our email newsletter.